tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market

Acumen Pharmaceuticals (ABOS) Income Statement

Compare
419 Followers

Acumen Pharmaceuticals Income Statement

Last quarter (Q3 2024), Acumen Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Acumen Pharmaceuticals's net income was $-29.77M. See Acumen Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.44M$ 1.70M
Gross Profit
$ -42.32M$ -169.00K$ -4.00K$ 1.43M$ 1.69M
Operating Expenses
$ 61.14M$ 45.24M$ 19.58M$ 9.35M$ 9.50M
Depreciation and Amortization
$ 184.00K$ 169.00K$ 4.00K$ 7.91M$ 7.80M
EBITDA
$ -51.61M$ -42.69M$ 61.58M$ 587.00K$ 119.00K
Operating Income
$ -61.14M$ -45.24M$ 61.57M$ -7.91M$ -7.80M
Other Income/Expenses
$ 8.77M$ 2.38M$ -81.02M$ 587.00K$ -102.00K
Pretax Income
$ -52.37M$ -42.86M$ -100.61M$ -7.33M$ -7.91M
Net Income
$ -52.37M$ -40.48M$ -181.68M$ -7.32M$ -7.86M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.08$ -1.00$ -4.49$ -0.18$ -0.20
Diluted EPS
$ -1.08$ -1.00$ -4.49$ -0.18$ -0.20
Weighted Average Shares Outstanding
48.49M 40.60M 40.47M 40.15M 40.15M
Weighted Average Shares Outstanding (Diluted)
48.61M 40.60M 40.47M 40.15M 40.15M
Currency in USD

Acumen Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis